Long-term effects on the brain after covid-19 | Pandemic PACT Tracker

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$590,720
Funder
Swedish Research Council
Principal Investigator
Magnus Gisslen
Research Location
Sweden
Lead Research Institution
University of Gothenburg
Research Priority Alignment
N/A

Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.

COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.

COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and death.

Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication.

Blood biomarkers for HIV infection with focus on neurologic complications-A review.